R&D Changing Faces: Pharma and biotech, February 2026 The pharmaceutical and biotech sectors have seen a flurry of executive movement this month.
R&D Changing Faces: Pharma and biotech, January 2026 The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.
R&D Changing Faces: Pharma and biotech hires, November and Decem... In our final batch of Changing Faces columns from 2025, we’re detailing a flurry of senior leadership appointments in recent months.
R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
Sales & Marketing Changing Faces – Pharma and biotech hires – August and Septe... It’s been a busy couple of months in the world of pharma hires as Merck KGaA and GSK both made some big changes at the top.
R&D Changing Faces – Pharma and Biotech Hires for July 2025 Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.
News Kidney biotech R1's $78m debut, and other biofinancings Biofinancing values have tailed off a bit after a strong start to 2026, but March has seen $50m+ rounds for R1, Crossbow, Excalipoint, and Prolium.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
